# US 2013/0157949 A1 · Novel Peptides for Wound Healing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157949 A1
- Document ID: US20130157949A1
- Status: Published application
- Kind: A1
- Application number: 13/704,471
- Filed: 2011-06-14
- Published: 2013-06-20
- Earliest claimed: 2010-06-14
- Assignees: Gene Signal International SA
- Inventors: Salman Al-Mahmood; Sylvie Colin
- Web page: https://patentgrep.com/patent/US20130157949A1

## CPC

- A61K 38/10: Peptides having 12 to 20 amino acids {(A61K38/043 - A61K38/046 take precedence)}
- A61K 38/08: Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61L 15/32: Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin {(A61L15/225 takes precedence)}
- A61L 15/44: Medicaments
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- C07K 7/06: having 5 to 11 amino acids
- C07K 7/08: having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)
- C07K 14/47: from mammals
- A61F 13/00063: {comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic (drug delivery dressings A61K9/70; chemical aspect of the additives A61L15/00)}
- A61F 2013/00927: {with biological activity, e.g. enzymes for debriding wounds or others, collagen or growth factors}
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61L 2300/25: Peptides having up to 20 amino acids in a defined sequence
- A61L 2300/412: Tissue-regenerating or healing or proliferative agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

The present invention relates to new peptides, pharmaceutical composition and cosmetic composition comprising them and their use for wound healing.

## Claims

### Claim at position 1

-15. (canceled)

### Claim 16

A peptide of less than 50 amino acids comprising one of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5 or SEQ ID NO: 6, or comprising a fragment of at least 8 amino acids of any of these.

### Claim 17 (depends on 16)

The peptide of claim 16, further defined as consisting of 8 to 30 amino acids.

### Claim 18 (depends on 16)

The peptide of claim 16, wherein said peptide is chemically modified by an acetylation and/or an amidation.

### Claim 19 (depends on 16)

A composition comprising at least one peptide or fragment of claim 16.

### Claim 20 (depends on 19)

The composition of claim 19, wherein the composition is a pharmaceutical composition comprising a pharmaceutically acceptable excipient.

### Claim 21 (depends on 20)

The pharmaceutical composition of claim 20, further comprising an haemostatic substance, a growth factor, an anti-infective substance, an analgesic substance, an anti-inflammatory substance and/or a combination thereof.

### Claim 22 (depends on 19)

The composition of claim 19, further defined as a cosmetic composition.

### Claim 23 (depends on 19)

The composition of claim 19, further defined as being in a form suitable for topical, injectable, oral and/or parenteral administration.

### Claim 24 (depends on 19)

The composition of claim 19, further defined as being in a form suitable for topical administration further defined as a lotion, salve, gel, cream, balsam, tincture, cataplasm, elixir, paste, spray, collyrium, drops, suspension, dispersion, hydrogel, ointment, emulsion or powder.

### Claim 25 (depends on 16)

A medical device comprising at least one peptide or fragment of claim 16.

### Claim 26 (depends on 25)

The medical device of claim 25, further defined as a bandage, gauze, wound or sore dressing, dermal patch, or adhesive tape.

### Claim 27 (depends on 16)

A method for healing a wound in a subject in need thereof, comprising administering to the subject an effective amount of at least one peptide or fragment of claim 16.

### Claim 28 (depends on 27)

The method of claim 27, wherein the peptide is administrated at a wound site.

### Claim 29 (depends on 27)

The method of claim 27, wherein the wound is an open wound.

### Claim 30 (depends on 27)

The method of claim 27, wherein the wound is a closed wound.

### Claim 31 (depends on 27)

The method of claim 27, wherein the wound is an acute or a chronic wound.

### Claim 32 (depends on 27)

The method of claim 27, wherein the subject is affected by Diabetes Mellitus.
